AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Sitaglize-M 50/1000 Tablet

Prescription Icon
Prescription Required

Marketer

Chemo Healthcare Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (1000mg)

Overview Sitaglize-M 50/1000 Tablet

This dual-action tablet, Sitaglize-M 50/1000, effectively manages elevated blood glucose in individuals with type 2 diabetes. This dual approach helps mitigate serious diabetic complications like renal impairment and vision loss, potentially lessening the risk of cardiovascular events. Sitaglize-M 50/1000 may be used independently or in conjunction with other antidiabetic therapies. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is personalized based on your health status, glucose levels, and current medications. Consuming it with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes efficacy; discontinuation should only occur under physician guidance. Adherence to the prescribed diet and exercise plan is crucial for effective diabetes control; lifestyle choices significantly influence management. Commonly reported side effects include nausea, diarrhea, vomiting, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential risk, particularly when combined with insulin or sulfonylureas; proper identification and management of low blood sugar is essential. This medication isn't universally suitable. Prior to use, inform your physician of any pre-existing kidney, liver, or heart conditions, pancreatic issues, or excessive alcohol consumption. Pregnant or lactating individuals require medical consultation before commencing treatment. Potential drug interactions exist; disclose all medications to your doctor to ensure safety. Alcohol consumption should be minimized due to its hypoglycemic effect. Your physician will monitor renal function and blood glucose levels throughout the treatment period.

Uses of Sitaglize-M 50/1000 Tablet

Managing type 2 diabetes

Major Benefits of Sitaglize-M 50/1000 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take Sitaglize-M 50/1000 with food.

Common Side effects of Sitaglize-M 50/1000 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitaglize-M 50/1000 Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the Sitaglize-M 50/1000 Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

How Sitaglize-M 50/1000 Tablet works:

Sitagliptin and metformin, combined as Sitaglize-M 50/1000 Tablet, work synergistically to manage blood glucose. Sitagliptin boosts insulin production by the pancreas, enhances insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and improves insulin responsiveness. This dual action results in superior blood sugar regulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Sitaglize-M 50/1000 Tablet ingestion poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Sitaglize-M 50/1000 tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against potential hazards prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitaglize-M 50/1000 tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitaglize-M 50/1000 tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Sitaglize-M 50/1000 tablets. Physician consultation is advised. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

The use of Sitaglize-M 50/1000 tablets is likely contraindicated for individuals with hepatic impairment and should be omitted. Medical advice is recommended.

What if you forget to take Sitaglize-M 50/1000 Tablet :

Should you forget to take a Sitaglize-M 50/1000 Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitaglize-M 50/1000 Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Sitaglize-M 50/1000 Tablet

Sitaglize-M 50/1000 tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged Sitaglize-M 50/1000 Tablet use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sitaglize-M 50/1000 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitaglize-M 50/1000 Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitaglize-M 50/1000 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (Sitaglize-M 50/1000) can cause lactic acidosis (MALA), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Sitaglize-M 50/1000 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitaglize-M 50/1000 Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitaglize-M 50/1000 Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitaglize-M 50/1000 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (Sitaglize-M 50/1000) can cause lactic acidosis (MALA—Metformin-associated lactic acidosis), a serious medical emergency resulting from excess blood lactic acid. This rare side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or a slow heart rate. If you experience these, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged Sitaglize-M 50/1000 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and balance problems), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitaglize-M 50/1000 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitaglize-M 50/1000 tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitaglize-M 50/1000 Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitaglize-M 50/1000 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (Sitaglize-M 50/1000) can cause lactic acidosis (MALA, Metformin-associated lactic acidosis), a serious medical emergency resulting from high blood lactic acid levels. This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged Sitaglize-M 50/1000 Tablet use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the instructions on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitaglize-M 50/1000 Table...
190
MRP 220
13% off